Results 131 to 140 of about 84,076 (240)

Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple Myeloma. [PDF]

J Cell Mol Med
Ronchetti D, Traini V, Silvestris I, Fabbiano G, Devecchi A, Torricelli F, Puccio N, Craparotta I, Bolis M, Piva R, Neri A, Agnelli L, Passamonti F, Bolli N, Taiana E.   +14 more
europepmc   +1 more source

Cancro do pâncreas

, 2022
Pancreatic cancer, due to the increasing incidence and mortality, as well as the difficulty in both early diagnosis and effective therapy, refractory nature of advanced disease and the worst prognosis among all types of cancer, has proved to be an extremely challenging disease, but also the most fearsome today.
openaire   +1 more source

Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis. [PDF]

Biomark Res
Angotzi F, Bevilacqua A, Serafin A, Danesin N, Cellini A, Leone G, D'Antiga M, Pagnin E, Frezzato F, Facco M, Piazza F, Trentin L, Visentin A.   +12 more
europepmc   +1 more source

Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation. [PDF]

Cancer Immunol Immunother
De Maria R, Donini C, Capellero S, Massa A, Galvagno F, Proment A, Vitali L, Vigna E, Landoni E, Dotti G, Leuci V, Accornero P, Conti LC, Olimpo M, Berrino E, Grignani G, Sapino A, Sangiolo D, Aresu L.   +18 more
europepmc   +1 more source

A subset of MMR-proficient colon cancers responds to neoadjuvant immunotherapy. [PDF]

Mol Oncol
Piumatti E, Germano G, Vitiello PP, Bardelli A.   +3 more
europepmc   +1 more source

Suscetibilidade genética no cancro: cancro da mama hereditário

, 2019
Cancer death is one of the major causes of mortality worldwide. It’s the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. It’s the product of a process involving complex interactions between environmental and endogenous factors.
openaire   +1 more source

Maladaptive somatic gene rescue as predisposition to JAK2 molecular abnormalities? Insights from an Israeli family. [PDF]

Ann Hematol
Borsani O, Gurnari C, Pietra D, Rumi E.
europepmc   +1 more source

The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer. [PDF]

Cancer Discov
Avolio M, Leto SM, Sassi F, Lupo B, Grassi E, Catalano I, Zanella ER, Vurchio V, Cottino F, Tsantoulis PK, Lazzari L, Luraghi P, Ferri M, Galimi F, Berrino E, Bellomo SE, Viviani M, Sogari A, Mauri G, Tosi F, Cruciani F, Sartore-Bianchi A, Siena S, Borghi F, Torri V, Élez E, Tabernero J, Nieva M, Montagut C, Tarazona N, Cervantes A, Tejpar S, Bardelli A, Marchiò C, Marsoni S, Bertotti A, Trusolino L.   +36 more
europepmc   +1 more source

Age-associated B cells and double-negative B cells: two sides of the same coin? The answer depends on the context. [PDF]

Front Aging
Lamprinou M, Sachinidis A, Dimitroulas T.   +2 more
europepmc   +1 more source

ANALOGHI DELL’INSULINA E CANCRO

il Diabete, 2019
Sciacca, Laura, Milluzzo, Agostino
openaire   +2 more sources